Overview A Study to Evaluate the Human Tolerance and Pharmacokinetics of LY03003 Status: Completed Trial end date: 2013-05-20 Target enrollment: Participant gender: Summary This study is to evaluate the human tolerance and pharmacokinetics of LY03003. Phase: Phase 1 Details Lead Sponsor: Luye Pharma Group Ltd.